Trademarkia Logo

Canada

C$
QELLQIA
SEARCHED

on 13 Mar 2023

Last Applicant/ Owned by

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

55218 Ingelheim

DE

Serial Number

2151131 filed on 24th Sept 2021

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

QELLQIA

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics; anti infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological and auto immune diseases and disorders; cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; cell based immune therapeutics for treatment of infectious diseases, namely viral infections.


Classification kind code

11

Mark Details


Serial Number

2151131

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 20th Mar 2024
Agent Changed
Submitted for opposition 22
on 13th Mar 2023
Search Recorded
Submitted for opposition 20
on 13th Mar 2023
Examiner's First Report
Submitted for opposition 223
on 13th Mar 2023
Total Provisional Refusal
Submitted for opposition 256
on 3rd Oct 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Dec 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Dec 2021
Formalized
Submitted for opposition 1
on 1st Dec 2021
Created
Submitted for opposition 228
on 24th Sept 2021
International Registration
Submitted for opposition 30
on 24th Sept 2021
Filed